Symmetry Investments LP Invests $465,000 in Core Scientific, Inc. (NASDAQ:CORZ)

Symmetry Investments LP acquired a new position in Core Scientific, Inc. (NASDAQ:CORZ) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 50,000 shares of the company’s stock, valued at approximately $465,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of CORZ. Banque Cantonale Vaudoise acquired a new position in shares of Core Scientific in the 2nd quarter worth $28,000. Rise Advisors LLC acquired a new position in shares of Core Scientific in the 2nd quarter worth $65,000. Aspect Partners LLC acquired a new position in shares of Core Scientific in the 1st quarter worth $29,000. Hexagon Capital Partners LLC acquired a new position in shares of Core Scientific in the 1st quarter worth $34,000. Finally, Divisadero Street Capital Management LP acquired a new position in shares of Core Scientific in the 2nd quarter worth $93,000.

Insider Buying and Selling at Core Scientific

In other Core Scientific news, insider Todd M. Duchene sold 7,321 shares of the business’s stock in a transaction dated Tuesday, June 25th. The stock was sold at an average price of $9.39, for a total value of $68,744.19. Following the transaction, the insider now owns 359,877 shares in the company, valued at $3,379,245.03. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Jarrod M. Patten purchased 4,000 shares of Core Scientific stock in a transaction on Wednesday, August 28th. The stock was bought at an average price of $9.70 per share, with a total value of $38,800.00. Following the completion of the transaction, the director now directly owns 279,239 shares of the company’s stock, valued at $2,708,618.30. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Todd M. Duchene sold 7,321 shares of the business’s stock in a transaction dated Tuesday, June 25th. The stock was sold at an average price of $9.39, for a total value of $68,744.19. Following the completion of the sale, the insider now directly owns 359,877 shares of the company’s stock, valued at approximately $3,379,245.03. The disclosure for this sale can be found here. Over the last 90 days, insiders have bought 12,761 shares of company stock worth $127,080 and have sold 27,655 shares worth $260,087. Corporate insiders own 32.00% of the company’s stock.

Analyst Ratings Changes

CORZ has been the topic of a number of recent research reports. BTIG Research lifted their target price on Core Scientific from $10.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, June 26th. HC Wainwright lifted their target price on Core Scientific from $11.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Cantor Fitzgerald reiterated an “overweight” rating and set a $20.00 price target on shares of Core Scientific in a report on Tuesday, September 3rd. Needham & Company LLC started coverage on Core Scientific in a report on Wednesday, September 4th. They set a “buy” rating and a $16.00 price target on the stock. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $17.00 price target on shares of Core Scientific in a report on Tuesday, September 10th. Eight research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $14.88.

Core Scientific Stock Performance

Shares of NASDAQ CORZ opened at $11.98 on Friday. The business’s 50-day moving average price is $10.19 and its two-hundred day moving average price is $7.05. Core Scientific, Inc. has a one year low of $2.61 and a one year high of $12.63.

Core Scientific (NASDAQ:CORZ) last issued its earnings results on Wednesday, August 7th. The company reported ($4.51) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($4.47). The business had revenue of $141.10 million during the quarter, compared to analysts’ expectations of $128.58 million. The company’s quarterly revenue was up 11.2% on a year-over-year basis. On average, sell-side analysts predict that Core Scientific, Inc. will post 0.01 EPS for the current year.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.